Document is current

Article History

Received: 8 January 2018

Accepted: 20 July 2018

First Online: 28 July 2018

Ethics approval

: Given that this study was performed without accessing patient information, approval of the ethics committee was not required.

: Not applicable

: A.C. received travel grants and meeting expenses from Abbott, MSD, BMS, Gilead and Astellas. A. K. received travel grants and meeting expenses from Gilead, Viofor and the World Health Organisation (WHO). A.K. is advisor of the Swiss Federal Office of Public Health concerning antibiotic resistance epidemiology in Switzerland. He provides annual resistance data without commentary to pharmaceutical company LEO and the Swiss government. J.M. received travel grants from Gilead and served on an advisory board for Astellas Switzerland and is co-applicant for SNSF grant 153,377 (PI: Andrea Endimiani) on carriage of resistant Enterobacteriaceae. D.H., L.B. and C.P.S. have no competing interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.